ACHILLION PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi &

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
ACHILLION PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Achillion Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 -- ACHN

NEW YORK, Oct. 25, 2013 (GLOBE NEWSWIRE) -- Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Connecticut on behalf of investors who purchased Achillion Pharmaceuticals, Inc. ("Achillion" or the "Company") (Nasdaq: ACHN ) common stock between August 8, 2012 and September 30, 2013.

For more information, click here: http://zlk.9nl.com/achillion-pharmaceuticals-achn/ .

The complaint alleges that the Company issued materially false and misleading statements regarding the safety and suitability of its hepatitis drug sovaprevir. In particular, it is alleged that Company misled investors regarding the drug's interactions with other drugs commonly administered to treat hepatitis and/or HIV; it is further alleged that the Company misled investors by stating that elevated liver enzymes in patients engaged in the clinical trials were transient and related to non-drug-related factors.

On July 1, 2013, the Company disclosed that the FDA had instituted a hold on sovaprevir after "elevations in liver enzymes" were noted in a Phase I healthy subject drug-drug interaction study. Then on September 27, 2013, it was announced that the FDA was maintaining its clinical hold on sovaprevir. Upon this news, shares of Achillion fell over 58% to a close of $3.02 on September 30, 2013.

If you suffered a loss in Achillion Pharmaceuticals you have until December 9, 2013 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/achillion-pharmaceuticals-achn/ .

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut, and Washington D.C.  The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits.  Attorney advertising. Prior results do not guarantee similar outcomes.

Levi & Korsinsky, LLP Joseph Levi, Esq. Eduard Korsinsky, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Understanding the Impact of China's Economic Slowdown

Updated Category News Views 173

The Impact of China's Economic Slowdown Today’s global markets are heavily influenced by China's economic situation, rather than a recession in the United States. Right now, China's recession is poised to have a significant effect on multiple sectors, especially by lowering oil prices and changing the course of global bond yields. How Oil Prices are Affected Falling...

Continue Reading
Key Insights from City of London Investment Group's Update

Updated Category News Views 113

City of London Investment Group Trading Update City of London Investment Group PLC (LSE: CLIG) announces its latest trading update for its financial year. This update highlights significant growth and strategic performance improvements in the management of its assets. The pre-close trading update reveals a noteworthy increase in funds under management (FuM), which rose by...

Continue Reading
Epsilor Unveils Revolutionary 6T Battery for Military Use

Updated Category News Views 231

Epsilor Launches Innovative 6T Battery for Military Applications Introducing the next step in military energy solutions, Epsilor Electric Fuel Ltd. has unveiled a remarkable 6T battery that sets a new standard with its impressive energy capacity of 4,400Wh/174Ah. This exceptional battery outperforms traditional Lead Acid variants by six times and exceeds competitors in...

Continue Reading
SunCar Technology Group Wins Major Walmart Car Wash Contract

Updated Category News Views 89

SunCar Technology Group Secures a Contract with Walmart SunCar Technology Group Inc. (NASDAQ: SDA) announced significant news that emphasizes its position within the automotive services industry. Recently, the company has successfully obtained an exclusive contract to manage Walmart China's upcoming premium membership car wash project, set to launch in 2025. Overview of...

Continue Reading
Strategic Innovations at Nightfood Holdings Set for 2025 Growth

Updated Category News Views 102

Nightfood Holdings, Inc.: A Vision for the Future in Hospitality Nightfood Holdings, Inc. (OTCQB: NGTF), a pioneer in utilizing AI-based robotic solutions, is gearing up for an exciting expansion strategy aimed at revolutionizing the hospitality sector. The company is eager to share its bold plans for growth and the transformative changes that lie ahead for the industry....

Continue Reading